[1]
“SEMAGLUTIDE IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME: CURRENT EVIDENCE AND REPRODUCTIVE BENEFITS”, IJITSS, vol. 4, no. 3(47), Sep. 2025, doi: 10.31435/ijitss.3(47).2025.3940.